| Product NDC: | 60505-2740 |
| Proprietary Name: | Verapamil |
| Non Proprietary Name: | Verapamil hydrochloride |
| Active Ingredient(s): | 120 mg/1 & nbsp; Verapamil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-2740 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200878 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121119 |
| Package NDC: | 60505-2740-1 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-2740-1) |
| NDC Code | 60505-2740-1 |
| Proprietary Name | Verapamil |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-2740-1) |
| Product NDC | 60505-2740 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Verapamil hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121119 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |